Dovato (Dolutegravir Sodium And Lamivudine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dovato. Always confirm against the full prescribing information.
100 interactions
Abemaciclib
Abemaciclib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Level 2 evidence
Abemaciclib
Abemaciclib may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Dolutegravir.
Level 2 evidence
Abrocitinib
The serum concentration of Dolutegravir can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Dolutegravir.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Dolutegravir.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Dolutegravir.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Dolutegravir.
Level 2 evidence
Acyclovir
The excretion of Acyclovir can be decreased when combined with Dolutegravir.
Level 2 evidence
Acyclovir
The risk or severity of adverse effects can be increased when Acyclovir is combined with Lamivudine.
Level 2 evidence
Adagrasib
The serum concentration of Dolutegravir can be increased when it is combined with Adagrasib.
Level 2 evidence
Adenine
The metabolism of Dolutegravir can be decreased when combined with Adenine.
Dovato (Dolutegravir Sodium And Lamivudine) has 1683 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Dovato (Dolutegravir Sodium And Lamivudine) has 18 major, 728 moderate, and 937 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dovato. Always confirm against the full prescribing information.